Based on the abovementioned research, we initially ascertained that TET1 was markedly expressed in cholangiocarcinoma tissues and correlated with prognosis through a tissue microarray and an in situ cholangiocarcinoma mouse model. This evidence concerns the gene TET1 and cholangiocarcinoma.